Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Accord launches 'cost saving' ADHD generic drug

Generic manufacturer Accord (formerly Actavis) has launched Delmosart prolonged-release methylphenidate tablets.

The schedule two controlled drug is used to treat attention deficit hyperactivity disorder (ADHD) in children aged six and over.

Delmosart is available in 18mg, 27mg, 36mg and 54mg tablets in pack sizes of 30, the manufacturer said. The different strengths have a trade price of £15.59, £18.41, £21.23 and £36.81 respectively.

Jonathan Wilson, Accord UK managing director, said the company is “committed” to offering a “market competitive price to both pharmacists and the NHS".

“Having listened to our customers’ needs, we are ow offering further potential cost savings to the NHS with the addition of Delmosart to our extensive range of products,” Mr Wilson said.

Accord products are available through all major wholesalers or directly from Accord.

To order, contact 0800 731 0370

Will you order this product?

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD008698

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel